Premature and multiple births in IVF are associated with pretreatment circulating LH/hCG receptor concentration

References

• Anderson, B.L. (2015). The time has come to consider neonatal outcomes when designing embryo transfer policies. British Journal of Obstetrics and Gynaecology, 122, 834. doi: 10.1111/1471-0528.13002.
   Google Scholar
• Arce, J.C., & Smitz, J. (2011). Exogenous hCG activity, but not endogenous LH activity, is positively associated with live birth rates in anovulatory infertility. Human Fertility, 14, 192–199. doi: http://dx.doi.org/10.3109/14647273.2011.587135.
   PubMed Web of Science ®Google Scholar
• Association of Clinical Embryologists, Bliss, British Fertility Society, British Infertility Counselling Association, Donor Conception Network, … Surrogacy, U.K. (2011). Multiple births from fertility treatment in the UK: a consensus statement. Human Fertility, 14, 151–153. doi: https://doi.org/http://dx.doi.org/10.3109/14647273.2011.592759.
   Web of Science ®Google Scholar
• Berndt, S., Perrier D’hauterive, S., Blacher, S., Péqueux, C., Lorquet, S., Munaut, C., … Foidart, J.M. (2006). Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. The FASEB Journal, 20, 2630–2632. doi: 10.1096/fj.06-5885fje.
   PubMed Web of Science ®Google Scholar
• Bourdiec, A., Bédard, D., Rao, C.V., & Akoum, A. (2013). Human chorionic gonadotropin regulates endothelial cell responsiveness to interleukin 1 and amplifies the cytokine-mediated effect on cell proliferation, migration and the release of angiogenic factors. American Journal of Reproductive Immunology, 70, 127–138. doi: 10.1111/aji.12080.
   PubMed Web of Science ®Google Scholar
• Chambers, A.E., Griffin, C., Naif, S.A., Mills, I., Mills, W.E., Syngelaki, A., … Banerjee, S. (2012). Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, Down’s syndrome, preterm delivery and preeclampsia. Reproductive Biology and Endocrinology, 10, 113. doi: 10.1186/1477-7827-10-113.
   PubMed Web of Science ®Google Scholar
• Chambers, A.E., Mills, W.E., Mercadé, I., Crovetto, F., Crispi, F., Rodriguez-Revenga Bodi, L., … Gratacos, E. (2014). The utility of circulating LHCGR as a predictor of Down’s syndrome in early pregnancy. BMC Pregnancy Childbirth, 14, 197. doi: 10.1186/1471-2393-14-197.
   PubMed Web of Science ®Google Scholar
• Chambers, A.E., Nayini, K.P., Mills, W.E., Lockwood, G.M., & Banerjee, S. (2011). Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation. Reproductive Biology and Endocrinology, 9, 161. doi: 10.1186/1477-7827-9-161https://doi.org/10.1186/1477-7827-9-161.
   PubMed Web of Science ®Google Scholar
• Crovetto, F., Figueras, F., Crispi, F., Triunfo, S., Pugia, M., Lasalvia, L., … Gratacós, E. (2015). Forms of circulating luteinizing hormone human chorionic gonadotropin receptor for the prediction of early and late preeclampsia in the first trimester of pregnancy. Fetal Diagnosis and Therapy, 38, 94–102. doi: 10.1159/000371516.
   PubMed Web of Science ®Google Scholar
• Filicori, M., Fazleabas, A.T., Huhtaniemi, I., Licht, P., Rao, C.V., Tesarik, J., & Zygmunt, M. (2005). Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility. Fertility and Sterility, 84, 275–284. doi: http://dx.doi.org/10.1016/j.fertnstert.2005.02.033.
   PubMed Web of Science ®Google Scholar
• Fluhr, H., Bischof-Islami, D., Krenzer, S., Licht, P., Bischof, P., & Zygmunt, M. (2008). Human chorionic gonadotropin stimulates matrix metalloproteinases-2 and -9 in cytotrophoblastic cells and decreases tissue inhibitor of metalloproteinases-1, -2, and -3 in decidualized endometrial stromal cells. Fertility and Sterility, 90, 1390–1395. doi: 10.1016/j.fertnstert.2007.08.023.
   PubMed Web of Science ®Google Scholar
• Kamphuis, E.I., van Wely, M., Repping, S., van der Veen, F., de Groot, C.J.M., Hompes, P., … Kazemier, B.M. (2015). Should the individual preterm birth risk be incorporated into the embryo transfer policy in in vitro fertilisation? A decision analysis. British Journal of Obstetrics and Gynaecology, 122, 825–833. doi: 10.1111/1471-0528.12980.
   Google Scholar
• Licht, P., von Wolff, M., Berkholz, A., & Wildt, L. (2003). Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertility and Sterility, 79, 718–723. doi: http://dx.doi.org/10.1016/S0015-0282(02)04822-7.
   PubMed Web of Science ®Google Scholar
• Malizia, B.A., Hacker, M.R., & Penzias, A.S. (2009). Cumulative live-birth rates after in vitro fertilization. The New England Journal of Medicine, 360, 236–243. doi: 10.1056/NEJMoa0803072.
   PubMed Web of Science ®Google Scholar
• Mansour, R., Tawab, N., Kamal, O., El-Faissal, Y., Serour, A., Aboulghar, M., & Serour, G. (2011). Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study. Fertility and Sterility, 96, 1370–1374.e1. doi: http://dx.doi.org/10.1016/j.fertnstert.2011.09.044.
   PubMed Web of Science ®Google Scholar
• McCormick, M.C., Litt, J.S., Smith, V.C., & Zupancic, J.A.F. (2011). Prematurity: an overview and public health implications. Annual Review of Public Health, 32, 367–379. doi: 10.1146/annurev-publhealth-090810-182459.
   PubMed Web of Science ®Google Scholar
• Moster, D., Lie, R.T., & Markestad, T. (2008). Long-term medical and social consequences of preterm birth. The New England Journal of Medicine, 359, 262–273. doi: 10.1056/NEJMoa0706475.
   PubMed Web of Science ®Google Scholar
• Schieve, L.A., Peterson, H.B., Meikle, S.F., Jeng, G., Danel, I., Burnett, N.M., & Wilcox, L.S. (1999). Live-birth rates and multiple-birth risk using in vitro fertilization. Journal of American Medical Association, 282, 1832–1838. doi: 10.1001/jama.282.19.1832.
   PubMed Web of Science ®Google Scholar
• Schumacher, A., Heinze, K., Witte, J., Poloski, E., Linzke, N., Woidacki, K., & Zenclussen, A.C. (2013). Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance. Journal of Immunology, 190, 2650–2658. doi: 10.4049/jimmunol.1202698.
   PubMed Web of Science ®Google Scholar
• Tsampalas, M., Gridelet, V., Berndt, S., Foidart, J.M., Geenen, V., & Perrier D’hauterive, S. (2010). Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. Journal of Reproductive Immunology, 85, 93–98. doi: http://dx.doi.org/10.1016/j.jri.2009.11.008.
   PubMed Web of Science ®Google Scholar
• van Heesch, M.M.J., Evers, J.L.H., van der Hoeven, M. a H B M., Dumoulin, J.C.M., van Beijsterveldt, C.E.M., Bonsel, G.J., … Dirksen, C.D. (2015). Hospital costs during the first 5 years of life for multiples compared with singletons born after IVF or ICSI. Human Reproduction, 30, 1481–1490. doi: 10.1093/humrep/dev059.
   PubMed Web of Science ®Google Scholar
• van Loendersloot, L., Repping, S., Bossuyt, P.M.M., van der Veen, F., & van Wely, M. (2014). Prediction models in in vitro fertilization; where are we? A mini review. Journal of Advanced Research, 5, 295–301. doi: http://dx.doi.org/10.1016/j.jare.2013.05.002.
   PubMedGoogle Scholar
• Vulliemoz, N.R., McVeigh, E., & Kurinczuk, J. Joint BFS RCOG Document. (2012). In vitro fertilisation: perinatal risks and early childhood outcomes. Human Fertility, 15, 62–68. doi: 10.3109/14647273.2012.663571.
   Web of Science ®Google Scholar